Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
SARS Antibody Test for Serosurveillance
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
wasabi.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
title
SARS Antibody Test for Serosurveillance
Creator
Hsueh, Po-Ren
Kao, Chuan-Liang
Lee, Chun-Nan
Wang, Chang
Ho, Mei-Shang
Chen, Li-Kuan
Lynn, Shugene
Sia, Charles
Chang, Yuan
Chu, Hsin
Dang, Edith
Fang, De
Guo Xia, Wei
Liu,
Shi, Kau
Tseng, ¶
Walfield, Alan
Wang, Jason
We, Taiwan
Xin, ¶
source
Medline; PMC
abstract
A peptide-based enzyme-linked immunosorbent assay (ELISA) can be used for retrospective serosurveillance of severe acute respiratory syndrome (SARS) by helping identify undetected chains of disease transmission. The assay was developed by epitope mapping, using synthetic peptides from the spike, membrane, and nucleocapsid protein sequences of SARS-associated coronavirus. The new peptide ELISA consistently detected seroconversion by week 2 of onset of fever, and seropositivity remained through day 100. Specificity was 100% on normal blood donor samples, on serum samples associated with infection by other pathogens, and on an interference panel. The peptide-based test has advantages of safety, standardization, and automation over previous immunoassays for SARS. The assay was used for a retrospective survey of healthy healthcare workers in Taiwan who treated SARS patients. Asymptomatic seroconversions were detected in two hospitals that had nosocomial disease.
has issue date
2004-09-01
(
xsd:dateTime
)
bibo:doi
10.3201/eid1009.040101
bibo:pmid
15498156
has license
no-cc
sha1sum (hex)
f2e236f0458f86706985c627ef88d40c8f037492
schema:url
https://doi.org/10.3201/eid1009.040101
resource representing a document's title
SARS Antibody Test for Serosurveillance
has PubMed Central identifier
PMC3320307
has PubMed identifier
15498156
schema:publication
Emerg Infect Dis
resource representing a document's body
covid:f2e236f0458f86706985c627ef88d40c8f037492#body_text
is
schema:about
of
named entity 'SERUM'
named entity 'ANTIBODY TEST'
named entity 'SARS'
named entity 'SAMPLES'
named entity 'CONVALESCENT'
named entity 'PROVIDING'
named entity 'PATIENTS'
named entity 'PHASE'
named entity 'SARS'
named entity 'CONFIRMED'
named entity 'disease transmission'
named entity 'nosocomial'
named entity 'seroconversion'
named entity 'Seroconversion'
named entity 'healthcare workers'
named entity 'rubella'
named entity 'serologic'
named entity 'seroconversion'
named entity 'peptide'
named entity 'SARS-CoV'
named entity 'pathogens'
named entity 'SARS'
named entity 'coronavirus'
named entity 'National Taiwan University Hospital'
named entity 'pathogens'
named entity 'peptide-based'
named entity 'Mycoplasma pneumoniae'
named entity 'EDTA'
named entity 'immunoassays'
named entity 'dextrose'
named entity 'nosocomial'
named entity 'coronavirus'
named entity 'molecular epidemiology'
named entity 'diagnostic assays'
named entity 'SARS'
named entity 'Medical Research'
named entity 'antibodies'
named entity 'Ho Ping'
named entity 'SARS'
named entity 'virus'
named entity 'biosafety level 3'
named entity 'infection'
named entity 'wild mammals'
named entity 'epidemiology'
named entity 'peptide-based'
named entity 'Center for Disease Control'
named entity 'human coronaviruses'
named entity 'Absorbance'
named entity 'peptides'
named entity 'HIV-1'
named entity 'recombinant proteins'
named entity 'SARS'
named entity 'goat'
named entity 'China'
named entity 'SARS-CoV'
named entity 'microbial'
named entity 'HIV'
named entity 'HIV'
named entity 'peptide'
named entity 'case definition'
named entity 'genomic sequence'
named entity 'National Taiwan University Hospital'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 5
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software